Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 13 Jan 2025 for Organogenesis Holdings Inc.. Read the official filing
Filing timeline
BuySaleAlan A. Ades
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Alan A. Ades: trading record in brief
All filings by Alan A. Ades on record concern Organogenesis Holdings Inc., in the capacity of board member. Between 6 May 2021 and 9 January 2025, the trades on record add up to 6 filings.
On the market, this insider has only sold: 1 sale, €52.3M in total.
Most recently, on 13 January 2025, the filings show a transaction in Organogenesis Holdings Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Alan A. Ades
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
6,401,945 shares0Class A Common StockSEC:0001062993-25-000728:0
6,401,945 shares0Class A Common StockSEC:0001062993-25-000727:0
1,710,552 shares0Class A Common StockSEC:0001062993-25-000287:0
1,710,552 shares0Class A Common StockSEC:0001062993-25-000286:0
3,887,500 shares@ US$16.40100.0% of flowClass A Common StockSEC:0001661181-21-000049:0
23,855,148 shares0Class A Common StockSEC:0001661181-21-000039:0
6 of 6 declarations
